The Latest Cardiac and Vascular News
PARIS, July 08, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, today announced the enrollment of the first patient in the Company’s REFRESH study […]
SAN FRANCISCO, July 08, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, and the Value Based Care Council (VBCC) of the National Association of Managed Care Physicians (NAMCP) today announced a one-of-a-kind partnership to help payers and managed care organizations (MCOs) […]
The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and […]
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood pressure treatments without additional side effects in earlier clinical research Lead candidate in Company’s pipeline of proprietary fixed-dose combination therapies targeting high unmet need in large patient populations suffering from non-communicable diseases such as CVD and Diabetes London, UK, 1 July 2021 – George Medicines, a late-stage drug development company focused […]
Optimized for remote patient monitoring and decentralized clinical trials CAMPBELL, Calif., June 30, 2021 /PRNewswire/ — Vivalink, a leading provider of connected healthcare solutions known for its unique medical wearable sensor data platform, today announces a newly enhanced temperature and cardiac electrocardiogram (ECG) monitor. Adopted by over 100 healthcare application partners and customers […]
Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) — The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative […]
Constructive Feedback Helps Cardiology Practices Understand How to Improve their Remote Monitoring Programs BEND, Ore.–(BUSINESS WIRE)–Vector Remote Care announced today the launch of a Remote Cardiac Monitoring (RCM) Maturity Assessment to help cardiology practices understand both the current state of their program and how to grow and improve it to drive value […]
– KARDIA-1 will Evaluate Efficacy and Safety of Quarterly and Biannual Regimens of Zilebesiran as Monotherapy – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced initiation of KARDIA-1, a global Phase 2 study evaluating the efficacy and safety of zilebesiran (pronounced “zile-BEE-siran” and formerly known […]
DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies DUBLIN, June 29, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company’s first […]
NANJING, China, June 28, 2021 /PRNewswire/ — Recently, Pulnovo Medical’s PADN-CFDA clinical trial, the world’s first pulmonary hypertension treatment device RCT study, has completed all patients enrollment, and will continue to assist each enrollment center to complete the follow-up of enrolled patients, data recovery, data cleaning, etc., and cooperate with the nation’s research […]
